The first suggestion that oral contraception might be responsible for cerebral vascular disease was made by Lorentz (1962) , when he described the case of a young woman who had been taking the contraceptive pill norethynodrel (Enavid) and had developed a left parietal vascular lesion. Other authors subsequently reported similar cases. Walsh et al. (1965) were the first to prove that the underlying disorder in these cases might be venous rather than arterial thrombosis. Among their 17 cases of cerebral vascular accidents in young women taking the contraceptive pill they reported one fatal case in which there was both arterial and venous thrombosis and one fatal case of pure venous thrombosis. Atkinson et al. (1970) described five further fatal cases. of cerebral venous thrombosis, and Buchanan and Brazinsky (1970) another. Pathological studies of two more fatal cases have been reported by Poltera (1972) .
Case 1 A married woman aged 36 had been taking the contraceptive pill norethisterone (Ortho-Novin) for 11 months. She presented with a four-day history of severe left-sided headache. On the day of admission she had vomited seven times. She was alert and orientated, and showed no abnormal neurological signs. Next morning she was noted to be slow in thought and speech. Later that day she became drowsy and irritable and developed a severe expressive dysphasia. Lumbar puncture showed 5 red blood cells/mm3 and a protein of 100 mg/ 100 ml. An electroencephalogram and a brain scan showed a left posterior temporal disturbance. A left carotid angiogram showed no evidence of arterial occlusion or aneurysm. There was slight swelling of the left cerebral hemisphere as shown by a 3-mm displacement of the anterior cerebral artery to the right. Oblique views in the late venous phase showed multiple small filling defects in the superior sagittal sinus.
Although it was not thought that these filling defects were directly responsible for her clinical state, they were taken as evidence of the presence of intracranial venous thrombosis and she was started on an intravenous heparin drip. Her clinical condition improved rapidly over the next 48 hours, so that she became alert and had only a mild residual dysphasia. After three days the heparin drip was replaced by oral warfarin. Her condition then deteriorated rapidly and she became almost totally aphasic with a mild right hemiparesis. It was found that her prothrombin time had returned to normal levels. The heparin drip was restarted and within 48 hours her dysphasia and right hemiparesis had almost fully recovered. After four days the heparin was replaced by oral warfarin again. Her recovery then proceeded uneventfully, and she was discharged home well 25 days after admission. Her anticoagulant treatment was continued for a further eight months and she was well a year after this treatment was discontinued.
Case 2 A married woman aged 27 had been taking the contraceptive pill norethisterone acetate (Minovlar) for six months. She presented with a seven-day history ofsevere occipital headache and a three-day history of vomiting and neck stiffness. She was alert and orientated. She showed severe neck stiffness. She had a very mild weakness of the St. Bartholomew's Hospital, London EClA 7BE, and Oldchurch Hospital, Romford BERNARD FAIRBURN, M.B., F.R.C.S., Consultant Neurological Surgeon right limbs with increased reflexes on that side. Both plantar responses were extensor. Lumbar puncture showed a cerebrospinal fluid pressure of 200 mm. The fluid contained 600 red blood cells/mm8 and a protein of 62 mg/100 ml. A brain scan showed increased uptake in the midfrontal region in the midline. A left carotid angiogram showed no abnormality in the arterial and capillary phases, but the oblique venous view showed complete absence of the superior sagittal and lateral sinuses. The whole venous circulation of the brain was being carried by irregular dilated venous channels.
During the few days while these investigations were being carried out, the patient developed bilateral sixth nerve palsies and early papilloedema. She was started on a heparin drip and this was subsequently changed to oral warfarin. Within a few days her headache cleared up and her other signs began to regress. She was discharged home well after five weeks, at which time her papilloedema and sixth nerve palsies had disappeared and her plantar responses had become flexor. Her anticoagulant treatment was continued for a further five months. She remained symptom and sign-free 14 months later.
Comment
The first reported use of anticoagulant drugs in the treatment of cerebral venous thrombosis was by Stansfield (1942) . He had had a fatal case of cerebral venous thrombosis in a puerperal patient of 25 years. A few months later he had a second case with identical clinical features and he treated her successfully with heparin. Krayenbuhl (1967) used anticoagulant drugs in 17 of his patients with cerebral venous thrombosis, apparently without any complication. I have been unable to trace any other specific references to the use of anticoagulants in the treatment of cerebral venous thrombosis.
Most standard textbooks advise against this treatment because of the danger of provoking intracranial haemorrhage. This advice appears to be based not on experience of the treatment of cerebral venous thrombosis but on the observed complication rate in the anticoagulant treatment of cerebral arterial disease. However, the dangers of cerebral venous thrombosis and cerebral arterial disease may not be strictly comparable. Although the true incidence of cerebral venous thrombosis as a complication of oral contraception is unknown, it is probably a rare condition. The fact that there are now 10 well-documented fatal examples of this disease suggests that it may be attended by a considerable mortality.
In the two cases reported above anticoagulant treatment appeared to arrest the progression of the venous thrombosis and full recovery followed. A third case of known puerperal thrombosis with extensive bilateral hemisphere infarction has also been treated by anticoagulant drugs with arrest of the disease and substantial neurological recovery. On the basis of these experiences it would seem reasonable to suggest that once a diagnosis of cerebral venous thrombosis has been made by angiography, anticoagulant treatment should be given. Such treatment can be combined with other therapeutic measures such as steroids and anticonvulsant drugs.
